Skip to main content
NANOVEU LIMITED logo

NANOVEU LIMITED — Investor Relations & Filings

Ticker · NVU ISIN · AU0000024796 LEI · 5299003PDOQ5DPU98119 ASX Manufacturing
Open in API
Filings indexed 628 across all filing types
Latest filing 2020-08-06 Director's Dealing
Country AU Australia
Listing ASX NVU

About NANOVEU LIMITED

https://nanoveu.com/

Nanoveu Limited specializes in the development of advanced materials and digital imaging solutions through nanotechnology. The company’s product portfolio includes EyeFly3D, a specialized film and software platform that enables glasses-free 3D visualization on mobile devices. Its Nanoshield product line features antimicrobial coatings and films that utilize copper ions to eliminate pathogens on frequently touched surfaces. Furthermore, the company is advancing EyeFyx technology, which aims to provide vision correction for individuals with presbyopia by manipulating digital screen output. Nanoveu focuses on integrating proprietary thin-film coatings with sophisticated algorithms to enhance display functionality and provide protective surface treatments across various consumer and commercial applications.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 3 pages 174.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the change, and contract interests. The document is about a director's personal share transactions and interests, which aligns with the definition of Director's Dealing filings. The document length is 3736 characters, which is consistent with a detailed notice rather than a brief announcement. Therefore, the document is best classified as a Director's Dealing report.
2020-08-06 English
Suspension from Official Quotation 2 pages 283.7KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Nanoveu Limited regarding a voluntary suspension of trading of its shares pending the release of a capital raising announcement. It references ASX Listing Rule 17.2 and states the suspension is requested until a capital raising announcement is made. The document is short (2003 characters) and does not contain financial statements or detailed financial data. It is an official notice related to trading suspension and capital raising but does not itself provide a capital/financing update report. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-08-05 English
Trading Halt 2 pages 155.4KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from Nanoveu Limited regarding a trading halt requested pending a capital raising announcement. It references ASX Listing Rules and the purpose is to inform the market about the halt and the pending capital raising announcement. The document is short (1912 characters) and does not contain any financial statements, detailed financial data, or report content. It is an announcement related to capital raising but does not itself provide details of the capital raising or financing activity. According to the classification rules, announcements about trading halts or pending capital raising announcements fall under Capital/Financing Update (CAP) as they relate to financing activities and capital structure changes. Therefore, the appropriate classification is CAP with high confidence.
2020-08-02 English
Appendix 4C - quarterly 11 pages 1.3MB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Activities Report and Appendix 4C For the Quarter Ended 30 June 2020' and is an ASX release. It contains detailed operational highlights, sales and marketing updates, regulatory approvals, and a quarterly cash flow report (Appendix 4C) with financial data for the quarter ended 30 June 2020. The content includes substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an interim or quarterly report. It is not merely an announcement of a report but contains the actual report data. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q2 2020
2020-07-30 English
Nanoveu Signs Thai and Malaysian Distribution Agreements 3 pages 163.7KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release dated 30 July 2020 from Nanoveu Limited announcing the signing of exclusive distribution agreements for its antiviral products in Thailand and Malaysia. The content focuses on the terms of the distribution agreements, the parties involved, and the strategic significance of the deal. There are no financial statements, earnings data, or regulatory certifications present. The document is a corporate announcement about a capital/financing related update, specifically about distribution agreements which impact the company's commercial operations and potential revenue streams. This fits best under the category of Capital/Financing Update (CAP). The document length is over 6000 characters, so it is not a brief announcement or a report publication notice. Therefore, the classification is CAP with high confidence.
2020-07-29 English
AGM Presentation 19 pages 1.5MB
AGM Information Classification · 100% confidence The document is titled 'AGM Presentation' dated 27th July 2020 and contains detailed slides about the company's year in review, technology, products, market pathway, corporate snapshot, and disclaimers. It is structured as a presentation with multiple slides and images (omitted here), typical of materials shared during an Annual General Meeting. There is no indication of full financial statements or detailed financial analysis that would classify it as an Annual Report (10-K) or Interim Report (IR). It is not a transcript, audit report, or any other regulatory filing. The content and format clearly match the description of AGM Information (AGM-R). The document length (14,056 characters) supports it being a full presentation rather than a brief announcement or notice.
2020-07-28 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.